Two New 4-Hydroxy-2-pyridone Alkaloids with Antimicrobial and Cytotoxic Activities from Arthrinium sp. GZWMJZ-606 Endophytic with Houttuynia cordata Thunb
Molecules · 2023
DOI: 10.3390/molecules28052192 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Ying Yin und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China. Hauptthemen laut MEDLINE: Houttuynia, Methicillin-Resistant Staphylococcus aureus, Anti-Infective Agents, Alkaloids. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Guizhou Provincial Science and Technology Projects, Light of the West" Talent Cultivation Program of Chinese Academy of Sciences.
Abstract (Originalsprache)
Two new 4-hydroxy-2-pyridone alkaloids furanpydone A and B (1 and 2), along with two known compounds N-hydroxyapiosporamide (3) and apiosporamide (4) were isolated from the endophytic fungus Arthrinium sp. GZWMJZ-606 in Houttuynia cordata Thunb. Furanpydone A and B had unusual 5-(7-oxabicyclo[2.2.1]heptane)-4-hydroxy-2-pyridone skeleton. Their structures including absolute configurations were determined on the basis of spectroscopic analysis, as well as the X-ray diffraction experiment. Compound 1 showed inhibitory activity against ten cancer cell lines (MKN-45, HCT116, K562, A549, DU145, SF126, A-375, 786O, 5637, and PATU8988T) with IC50 values from 4.35 to 9.72 µM. Compounds 1, 3 and 4 showed moderate inhibitory effects against four Gram-positive strains (Staphylococcus aureus, methicillin-resistant S. aureus, Bacillus Subtilis, Clostridium perfringens) and one Gram-negative strain (Ralstonia solanacarum) with MIC values from 1.56 to 25 µM. However, compounds 1–4 showed no obvious inhibitory activity against two Gram-negative bacteria (Escherichia coli and Pseudomonas aeruginosa) and two pathogenic fungi (Candida albicans and Candida glabrata) at 50 µM. These results show that compounds 1–4 are expected to be developed as lead compounds for antibacterial or anti-tumor drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China.
- Key Laboratory of Chemistry for Natural Products of Guizhou Province, Chinese Academy of Sciences, Guiyang 550014, China.
- School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang 550025, China.
- Key Laboratory of Marine Drugs, Ministry of Education of China, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China.
ORCID-Profile: Weiming Zhu
Förderung
- National Natural Science Foundation of China
- Guizhou Provincial Science and Technology Projects
- Light of the West" Talent Cultivation Program of Chinese Academy of Sciences
- GMU
- 100 Leading Talents of Guizhou Province
- “Light of the West” Talent Cultivation Program of Chinese Academy of Sciences
Zitieren
APA
Yin, Y., Wang, D., Wu, D., He, W., Zuo, M., Zhu, W., Xu, Y., & Wang, L. (2023). Two New 4-Hydroxy-2-pyridone Alkaloids with Antimicrobial and Cytotoxic Activities from Arthrinium sp. GZWMJZ-606 Endophytic with Houttuynia cordata Thunb. Molecules. https://doi.org/10.3390/molecules28052192
Vancouver
Yin Y, Wang D, Wu D, He W, Zuo M, Zhu W, et al. Two New 4-Hydroxy-2-pyridone Alkaloids with Antimicrobial and Cytotoxic Activities from Arthrinium sp. GZWMJZ-606 Endophytic with Houttuynia cordata Thunb. Molecules. 2023. doi:10.3390/molecules28052192
BibTeX
@article{Yin2023,
author = {Yin, Ying and Wang, Dongyang and Wu, Dan and He, Wenwen and Zuo, Mingxing and Zhu, Weiming and Xu, Yanchao and Wang, Liping},
title = {Two New 4-Hydroxy-2-pyridone Alkaloids with Antimicrobial and Cytotoxic Activities from Arthrinium sp. GZWMJZ-606 Endophytic with Houttuynia cordata Thunb},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28052192}
}
EUVIMED